- Home
- STIM vs DAVA Comparison
STIM vs DAVA Comparison
Compare STIM & DAVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | STIM | DAVA |
|---|---|---|
| Founded | 2003 | 2000 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 140.6M | 148.0M |
| IPO Year | 2018 | 2015 |
Fundamental Metrics
Financial Performance| Metric | STIM | DAVA |
|---|---|---|
| Price | $1.23 | $2.70 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 9 |
| Target Price | $3.00 | ★ $13.50 |
| AVG Volume (30 Days) | ★ 1.6M | 449.6K |
| Earning Date | 05-05-2026 | 05-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 57.25 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $52,776,000.00 | N/A |
| Revenue This Year | $11.10 | N/A |
| Revenue Next Year | $11.92 | $4.07 |
| P/E Ratio | ★ N/A | $20.02 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.80 | $2.63 |
| 52 Week High | $4.84 | $16.05 |
Technical Indicators
Market Signals| Indicator | STIM | DAVA |
|---|---|---|
| Relative Strength Index (RSI) | 42.89 | 32.37 |
| Support Level | $1.21 | N/A |
| Resistance Level | $1.75 | $3.58 |
| Average True Range (ATR) | 0.12 | 0.19 |
| MACD | -0.01 | 0.02 |
| Stochastic Oscillator | 7.27 | 7.32 |
Price Performance
Historical ComparisonAbout STIM Neuronetics Inc.
Neuronetics Inc a commercial-stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advance Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulation, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advance Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address the existing treatment options. The company operates in two segments: medical devices and clinic services.
About DAVA Endava plc (each representing one)
Endava is a next-generation IT services company that primarily assists clients with their digital transformation efforts by creating customized software for them. The company was founded in 2006 in the UK, and it continues to generate the majority of revenue in the UK and Europe. Endava's client base is concentrated in the payments and financial services, technology, media, and telecom industries.